Author:
Río J.,Tintoré M.,Sastre-Garriga J.,Nos C.,Castilló J.,Tur C.,Comabella M.,Montalban X.
Subject
Clinical Neurology,Neurology
Reference25 articles.
1. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial;The IFNB Multiple Sclerosis Study Group;Neurology,1993
2. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. 1995;Johnson;Neurology,2001
3. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis;PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group;Lancet,1998
4. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG);Jacobs;Ann Neurol,1996
5. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis;Kappos;N Engl J Med,2010
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献